| Topic List | Page List: 1 |
|---|---|
| Topic | Stock Topic 22 |
| Lopen 02/19/21 2:17:31 PM #212: | I'm thinking TRVN will double+ in the next year. Catalysts you're looking forward to is the DEA releasing some sorta statement that their drug is cute and pop or good test results from their pipeline or just revenue increasing. But honestly with that I'm holding long. I see it as a dividend stock at some point and if I have a bucket of shares I got cheap that's gonna be awesome. Seems like the management for TRVN is really smart. They held off on offering after the FDA approval until their next quarter started-- I think they want to have the quarters look positive in terms of stock price to the best they can to draw investors in. I think they can stave off cash burn now as they have income coming in from some China partnership that gives them milestone payments for their drug (which will probably be widely used over there) and shouldn't require another offering for a good long while, which would be your main fear with a company like that that isn't currently generating quite enough revenue to run in the green yet. Though it does have that typical Pharma pop that you can probably sell the news on either of those then buy back in cheaper. But yeah not why I'm holding it. --- No problem! This is a cute and pop genocide of love! ... Copied to Clipboard! |
| Topic List | Page List: 1 |